FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229

K Number: K011306 · Decision May 16, 2001
Classifications
1
FEI Numbers
90
Registration Numbers
90
Same Product Code
89
Applicant Total
19
Review Days
16

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F229
K Number
K011306
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
862.3170
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Syva Co., Dade Behring, Inc.
Date Received
April 30, 2001
Decision Date
May 16, 2001
Product Code
JXM
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
JXM Enzyme Immunoassay, Benzodiazepine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (JXM), ordered by most recent decision date.

View all

Other Clearances by Syva Co., Dade Behring, Inc.

K Number Device Name
K011920 EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H229
K011620 EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N229
K011605 EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q229
K011300 EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N229
K011161 MODIFICATION TO THE EMIT II PLUS PHENCYCLIDINE ASSAY, MODEL OSR9J229
K011289 EMIT II PLUS OPIATE ASSAY, MODEL OSR9B229
K011163 MODIFICATION TO THE EMIT II PLUS PROPOXYPHENE ASSAY, MODEL OSR9G229
K011166 MODIFICATION TO EMIT 2000 THEOPHYLLINE ASSAY, MODEL OSR 4P229
K011164 MODIFICATION TO THE EMIT II PLUS METHAQUALONE ASSAY, MODEL OSR9Q229
K011162 MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY
Search all 19 clearances from Syva Co., Dade Behring, Inc. →